|
1
|
Tsao CW, Aday AW, Almarzooq ZI, Alonso A,
Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP,
Commodore-Mensah Y, et al: Heart disease and stroke statistics-2022
update: A report from the American heart association. Circulation.
145:e153–e639. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Arnett DK, Blumenthal RS, Albert MA,
Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A,
Lloyd-Jones D, McEvoy JW, et al: 2019 ACC/AHA guideline on the
primary prevention of cardiovascular disease: A report of the
American college of Cardiology/American Heart association task
force on clinical practice guidelines. Circulation. 140:e596–e646.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Goff DC Jr, Lloyd-Jones DM, Bennett G,
Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy
D, O'Donnell CJ, et al: 2013 ACC/AHA guideline on the assessment of
cardiovascular risk: A report of the American College of
Cardiology/American Heart association task force on practice
guidelines. Circulation. 129:S49–S73. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Torkamani A, Wineinger NE and Topol EJ:
The personal and clinical utility of polygenic risk scores. Nat Rev
Genet. 19:581–590. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bebo A, Jarmul JA, Pletcher MJ, Hasbani
NR, Couper D, Nambi V, Ballantyne CM, Fornage M, Morrison AC, Avery
CL and de Vries PS: Coronary heart disease and ischemic stroke
polygenic risk scores and atherosclerotic cardiovascular disease in
a diverse, population-based cohort study. PLoS One.
18(e0285259)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Motamed N, Rabiee B, Perumal D, Poustchi
H, Miresmail SJ, Farahani B, Maadi M, Saeedian FS, Ajdarkosh H,
Khonsari MR, et al: Comparison of cardiovascular risk assessment
tools and their guidelines in evaluation of 10-year CVD risk and
preventive recommendations: A population based study. Int J
Cardiol. 228:52–57. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mars N, Koskela JT, Ripatti P, Kiiskinen
TTJ, Havulinna AS, Lindbohm JV, Ahola-Olli A, Kurki M, Karjalainen
J, Palta P, et al: Polygenic and clinical risk scores and their
impact on age at onset and prediction of cardiometabolic diseases
and common cancers. Nat Med. 26:549–557. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Marston NA, Pirruccello JP, Melloni GEM,
Koyama S, Kamanu FK, Weng LC, Roselli C, Kamatani Y, Komuro I,
Aragam KG, et al: Predictive utility of a coronary artery disease
polygenic risk score in primary prevention. JAMA Cardiol.
8:130–137. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ashley EA, Hershberger RE, Caleshu C,
Ellinor PT, Garcia JG, Herrington DM, Ho CY, Johnson JA, Kittner
SJ, Macrae CA, et al: Genetics and cardiovascular disease: A policy
statement from the American Heart association. Circulation.
126:142–157. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Aragam KG and Natarajan P: Polygenic
scores to assess atherosclerotic cardiovascular disease risk:
Clinical perspectives and basic implications. Circ Res.
126:1159–1177. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fahed AC, Wang M, Homburger JR, Patel AP,
Bick AG, Neben CL, Lai C, Brockman D, Philippakis A, Ellinor PT, et
al: Polygenic background modifies penetrance of monogenic variants
for tier 1 genomic conditions. Nat Commun. 11(3635)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Khera AV, Chaffin M, Aragam KG, Haas ME,
Roselli C, Choi SH, Natarajan P, Lander ES, Lubitz SA, Ellinor PT
and Kathiresan S: Genome-wide polygenic scores for common diseases
identify individuals with risk equivalent to monogenic mutations.
Nat Genet. 50:1219–1224. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lambert SA, Abraham G and Inouye M:
Towards clinical utility of polygenic risk scores. Hum Mol Genet.
28:R133–R142. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
O'Sullivan JW, Raghavan S, Marquez-Luna C,
Luzum JA, Damrauer SM, Ashley EA, O'Donnell CJ, Willer CJ and
Natarajan P: American Heart Association Council on Genomic and
Precision Medicine et al. Polygenic risk scores for
cardiovascular disease: A scientific statement from the American
heart association. Circulation. 146:e93–e118. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Panagiotou N, Bersimis F, Fotis A, Sagonas
A, Ntoumou E, Salata E, Kallistratos M and Psychogios A: P273:
Adjusted polygenic score: Translation of a new concept for
cardiovascular disease prevention and management. Genetics in
Medicine Open. 1(100301)2023.
|
|
16
|
Panagiotou N and Chatziandreou E: MT5
adjusted polygenic risk score enables personalized cardiovascular
disease prevention and clinical management. Value in Health.
25:S378–S379. 2022.
|
|
17
|
Hasbani NR, Ligthart S, Brown MR, Heath
AS, Bebo A, Ashley KE, Boerwinkle E, Morrison AC, Folsom AR,
Aguilar D and de Vries PS: American heart association's life's
simple 7: Lifestyle recommendations, polygenic risk, and lifetime
risk of coronary heart disease. Circulation. 145:808–818.
2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mujwara D, Henno G, Vernon ST, Peng S,
Domenico PD, Schroeder B, Busby GB, Figtree GA and Bottà G:
Integrating a polygenic risk score for coronary artery disease as a
risk-enhancing factor in the pooled cohort equation: A
cost-effectiveness analysis study. J Am Heart Assoc.
11(e025236)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Riveros-Mckay F, Weale ME, Moore R, Selzam
S, Krapohl E, Sivley RM, Tarran WA, Sørensen P, Lachapelle AS,
Griffiths JA, et al: Integrated polygenic tool substantially
enhances coronary artery disease prediction. Circ Genom Precis Med.
14(e003304)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hindy G, Aragam KG, Ng K, Chaffin M, Lotta
LA and Baras A: Regeneron Genetics Center. Drake I, Orho-Melander
M, Melander O, et al: Genome-Wide polygenic score, clinical risk
factors, and long-term trajectories of coronary artery disease.
Arterioscler Thromb Vasc Biol. 40:2738–2746. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Saadatagah S, Naderian M, Dikilitas O,
Hamed ME, Bangash H and Kullo IJ: Polygenic risk, rare variants,
and family history. JACC Adv. 2(100567)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Elliott J, Bodinier B, Bond TA,
Chadeau-Hyam M, Evangelou E, Moons KGM, Dehghan A, Muller DC,
Elliott P and Tzoulaki I: predictive accuracy of a polygenic risk
score-enhanced prediction model vs a clinical risk score for
coronary artery disease. JAMA. 323:636–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Isgut M, Sun J, Quyyumi AA and Gibson G:
Highly elevated polygenic risk scores are better predictors of
myocardial infarction risk early in life than later. Genome Med.
13(13)2021.PubMed/NCBI View Article : Google Scholar
|
